Hardy Alexander

Biomarin Pharmaceutical Inc · Chief Executive Officer

Hardy Alexander is listed in public filings as director, officer: Chief Executive Officer. This Hardy Alexander insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Biomarin Pharmaceutical Inc (BMRN). Investors use Hardy Alexander's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Biomarin Pharmaceutical IncBMRN$12M214.6k sharesGrant / ExerciseMar 17, 2026$238.3K4.3k shares$56.05--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Biomarin Pharmaceutical IncBMRN$5.1M89.2k sharesGrant / ExerciseMar 16, 2026$5.1M89.2k shares$57.43--
Biomarin Pharmaceutical IncBMRN--218.9k sharesGrant / ExerciseMar 16, 2026Disclosure amount unavailable62.4k shares----
Biomarin Pharmaceutical IncBMRN$9.2M156.4k sharesGrant / ExerciseMar 13, 2026$172.1K2.9k shares$58.51--
Biomarin Pharmaceutical IncBMRN$8.8M159.4k sharesGrant / ExerciseDec 1, 2025$911.8K16.6k shares$55.03--
Biomarin Pharmaceutical IncBMRN$9.5M176k sharesGrant / ExerciseApr 30, 2025$20.3K375 shares$54.14--
Biomarin Pharmaceutical IncBMRN$4.4M61.8k sharesGrant / ExerciseMar 17, 2025$4.4M61.8k shares$71.55--
Biomarin Pharmaceutical IncBMRN--175.6k sharesGrant / ExerciseMar 17, 2025Disclosure amount unavailable44.4k shares----
Biomarin Pharmaceutical IncBMRN$9.1M131.2k sharesGrant / ExerciseMar 14, 2025$203.7K2.9k shares$69.44--
Biomarin Pharmaceutical IncBMRN$8.9M134.2k sharesGrant / ExerciseNov 29, 2024$943.9K14.3k shares$66.03--
Biomarin Pharmaceutical IncBMRN$8.3M148.5k sharesGrant / ExerciseOct 31, 2024$16.8K300 shares$56.01--